戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 fect may be related to flavanones present in grapefruit.
2 ing and storage on phytochemicals in Rio Red grapefruit.
3 ed for artificial degreening of early season grapefruits.
4 nt activity between organic and conventional grapefruits.
5  degreening could be utilized to enhance the grapefruit aesthetic quality, with minimal effect on nut
6 he fruit of some citrus species (pummelo and grapefruit) and undesirable in others (oranges and manda
7 citrus types including sweet orange, citron, grapefruit, and a trifoliate hybrid using the identified
8  roasted coffee, cooked meat, passion fruit, grapefruit, and guava.
9                           Pineapple, orange, grapefruit, apple, clementine, and pomelo were investiga
10  and red wine (associated with CHD and CVD); grapefruit (associated with CHD); strawberries (associat
11 05) in organic grapefruits over conventional grapefruits at harvest and storage in E-1.
12 sicum character of MPs and the passion fruit/grapefruit character due to volatile thiols.
13 ent the transformation of mature tissue from grapefruit, citron, and a trifoliate hybrid.
14  four protein families, were isolated from a grapefruit (Citrus paradisi Macf. Cv. Marsh) immature fr
15 f degreening and storage period on Star Ruby grapefruit (Citrus paradisi Macf.) bioactive compounds.
16 C) on the bioactive compounds in 'Star Ruby' grapefruit (Citrus paradisi Macf.) were examined.
17 not synthesizing oil) from the peel of young grapefruit (Citrus x paradisi 'Duncan'), isolated RNA, a
18      Here we show that nanoparticles made of grapefruit-derived lipids, which we call grapefruit-deri
19                                              Grapefruit-derived nanovectors are less toxic than nanop
20 nstrate the in vivo targeting specificity of grapefruit-derived nanovectors by co-delivering therapeu
21                 The therapeutic potential of grapefruit-derived nanovectors was further demonstrated
22  of grapefruit-derived lipids, which we call grapefruit-derived nanovectors, can deliver chemotherape
23  glycoside is contained in blood oranges and grapefruits, displayed an IC(5)(0) of 50 nM and is to ou
24 ain taste and certain bioactive compounds of grapefruits during prolonged storage at low temperature.
25  levels of DHB were observed in conventional grapefruits during the second (4.7 +/- 0.2 mug/g), third
26 ine, mixed fruit juice, date, apple, orange, grapefruit, egg and honey for the determination of total
27 ect on the phytochemical contents of Rio Red grapefruit, especially after 7 days of storage.
28 ever, clinical data regarding the effects of grapefruit flavanone consumption on vascular function ar
29  DPPH levels were moderately correlated with grapefruit flavanone content, variability in the individ
30    More importantly, we demonstrate that the grapefruit flavonoid naringenin, previously shown to inh
31                                              Grapefruits grown under organic or conventional systems
32 paring the extreme consumption categories of grapefruit (>/= three times per week v never) was 1.41 (
33                                              Grapefruits harvested in November 2008 (E-1) and Februar
34 rins as mediators of the interaction between grapefruit juice (GFJ) and the model CYP3A4 substrate fe
35 avanones in the long-term effects induced by grapefruit juice (GFJ) consumption on vascular function
36                                              Grapefruit juice (GFJ) enhances the systemic exposure of
37  complex mixtures, flavonoids extracted from grapefruit juice are separated by high-performance liqui
38  in risk was seen for each 240-mL serving of grapefruit juice consumed daily.
39 yte concentrations of CYP3A4 measured before grapefruit juice consumption correlated with the increas
40                                 In addition, grapefruit juice delayed the time to peak concentration
41                                              Grapefruit juice did not alter liver CYP3A4 activity, co
42 er commonly used medications when taken with grapefruit juice has been assumed to be due to inhibitio
43                                              Grapefruit juice increased the area under the concentrat
44           To evaluate the effect of repeated grapefruit juice ingestion on CYP3A4 expression, 10 heal
45 udy tested the hypothesis that acceptance of grapefruit juice is influenced, in part, by sensitivity
46        This study investigated the effect of grapefruit juice on cyclosporine A (CsA) bioavailability
47  conclude that a mechanism for the effect of grapefruit juice on oral felodipine kinetics is its sele
48 ir usual dose of CsA with either 8 ounces of grapefruit juice or 8 ounces of water.
49 ken with either the 1st or the 16th glass of grapefruit juice relative to water (r = 0.67, P = 0.043,
50 xpression, 10 healthy men were given 8 oz of grapefruit juice three times a day for 6 d.
51 study clearly indicate that frauds by adding grapefruit juice to orange juice can be detected at perc
52             The adulterations by addition of grapefruit juice were studied by 3D-front-face fluoresce
53 ta suggest that concurrent administration of grapefruit juice with CsA will delay the absorption of C
54 Naringin, the principal bitter ingredient of grapefruit juice, has been implicated in the regulation
55                   Before and after receiving grapefruit juice, small bowel and colon mucosal biopsies
56 o assess the adulteration of orange juice by grapefruit juice.
57 lso associated with reduced acceptability of grapefruit juice.
58  (4-75%) for apple juice and 37% (1-85%) for grapefruit juice.
59 =0.029) and 12-hr trough (244+/-214 ng x ml [grapefruit juice] vs. 132+/-56 ng x ml [water], P=0.09),
60 entration compared with water (5.4+/-3.0 hr [grapefruit juice] vs. 2.8+/-0.8 hr [water], P=0.025).
61 n versus time curve (4218+/-1497 ng x hr/ml [grapefruit juice] vs. 3415+/-1288 ng x hr/ml [water], P=
62 hange peak concentration (734+/-290 ng x ml [grapefruit juice] vs. 708+/-305 ng x ml [water], P=0.76)
63 the separation between pineapple, orange and grapefruit juices, and their admixtures down to 1% adult
64 st pathogenicity and produced no symptoms on grapefruit leaves inoculated by either pressure infiltra
65 s for other citrus fruits (including orange, grapefruit, lemon, yuzu, sudachi, ponkan, and iyokan) we
66 bergamot, lemon, bigarade, orange, mandarin, grapefruit, lime) by analysing the non-volatile oxygenat
67 nted with an array of Citrus fruit: oranges, grapefruit, mandarins (tangerines), lemons and limes.
68 eberry, raspberry, cranberry, cherry, apple, grapefruit, mango, kiwifruit, pineapple, melon, coconut,
69 were significantly higher (P0.05) in organic grapefruits over conventional grapefruits at harvest and
70               The irrigation necessities for grapefruit production are very high.
71 ntatively identified in the crude extract of grapefruit seeds by ESI mass spectrometry in both positi
72            Among individual citrus products, grapefruit showed the most apparent association with ris
73 ene was sufficient for systemic infection of grapefruit trees and the p33 or the p13 gene was suffici
74 r and transformed into three CTV susceptible grapefruit varieties.
75  unshiu and specific IgE test for orange and grapefruit were positive.
76                            Freshly harvested grapefruits were degreened in commercial packing shed fo
77                                              Grapefruits were degreened with 3.5 mul/l of ethylene at
78                             Furthermore, the grapefruits were stored at 11 degrees C for 3 weeks and
79   Degreening improved the peel colour of the grapefruit without affecting total soluble solids or aci

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。